news2013 sec
TRANSCRIPT
![Page 1: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/1.jpg)
![Page 2: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/2.jpg)
Ecocardiografía
Medicina nuclear
Cardio TC
Cardio RMN
![Page 3: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/3.jpg)
Hubert et al. J Am Coll Cardiol 2013; 62: 1384-92
![Page 4: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/4.jpg)
Ruschitzka et al. New Eng J Med 2013; 369: 1395-405
![Page 5: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/5.jpg)
Makani et al. J Am Coll Cardiol 2012; 60: 1393-401
![Page 6: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/6.jpg)
Makani et al. J Am Coll Cardiol 2012; 60: 1393-401
![Page 7: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/7.jpg)
Makani et al. J Am Soc Echocardiogr 2013; 26:72-76
![Page 8: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/8.jpg)
Gaibazzi et al. J Am Coll Cardiol Img 2013; 6:1-12
![Page 9: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/9.jpg)
Gaibazzi et al. J Am Coll Cardiol Img 2013; 6:1-12
![Page 10: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/10.jpg)
Smith et al. J Am Soc Echocardiogr 2013; 26:359-69
![Page 11: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/11.jpg)
Sinning et al. J Am Coll Cardiol 2013; 62:11-20
![Page 12: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/12.jpg)
Lauten et al. J Am Coll Cardiol 2013; 61:1799-808
![Page 13: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/13.jpg)
González Cánovas et al. Rev Esp Cardiol 2013; 66(4):255-260
![Page 14: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/14.jpg)
Clavel et al. J Am Coll Cardiol 2012; 60:1259-67
![Page 15: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/15.jpg)
Ozkan et al. Circulation 2013; 128:622-631
![Page 16: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/16.jpg)
Eleid et al. Circulation 2013; 128:1781-89
![Page 17: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/17.jpg)
Pui-Wai Lee. Circulation 2013; 127:832-841
![Page 18: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/18.jpg)
Thavendiranathan et al. Circ Cardiovasc Imaging 2013;6:125-133
![Page 19: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/19.jpg)
Ecocardiografía
Medicina nuclear
Cardio TC
Cardio RMN
![Page 20: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/20.jpg)
Saby et al. J Am Coll Cardiol 2013; 61: 2374-82
![Page 21: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/21.jpg)
Saby et al. J Am Coll Cardiol 2013; 61: 2374-82
![Page 22: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/22.jpg)
![Page 23: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/23.jpg)
Ecocardiografía
Medicina nuclear
Cardio TC
Cardio RMN
![Page 24: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/24.jpg)
![Page 25: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/25.jpg)
Min et al. J Am Coll Cardiol 2011; 58: 849-60
CONFIRM
COronary CT angiography evaluatioN For Clinical outcomes InteRnational Multicenter registry
24.775 pacientes
Mortalidad
Sin enf coronaria conocida
2.3 años
Sospecha34% asintomáticos
12% perfil no cardíacoAusencia de enfermedad
Mortalidad 0.28%/año
![Page 26: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/26.jpg)
Nasir et al. Circ Cardiovasc Img2012; 5: 467-473
![Page 27: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/27.jpg)
MESAMulti Ethnic Study of Atherosclerosis Budoff et al. J Am Coll Cardiol 2013; 61: 1231-9
3.8veces
6.778 pacientes
Eventos coronarios
Sin enf coronaria conocida
7.6 años
Score calcio repetido
![Page 28: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/28.jpg)
![Page 29: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/29.jpg)
CXDA CD
Si el estudio es técnicamente correcto y negativo
Se descarta de forma fiable enfermedad coronaria
Prácticamente NO HAY falsos negativos
![Page 30: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/30.jpg)
ROMICAT
2 años de seguimiento
Schlett et al. J Am Coll Cardiol Img 2011; 4: 481-91
Eventos 2 años
Estenosis > 50% 30.3%
Estenosis < 50% 4.6%
Sin lesiones 0%
Seguimiento 90% pacientes. 6.8% eventos (IAM o revascularización)
TC 64(ciego)
![Page 31: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/31.jpg)
CXDA CD
Si el estudio es técnicamente correcto y negativo
Se descarta de forma fiable enfermedad coronaria
Prácticamente NO HAY falsos negativos
![Page 32: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/32.jpg)
15,207sujetos
Sospecha enfermedad coronaria
2.3±1.2 años
Shaw et al. J Am Coll Cardiol 2012; 60:2103-14
Riesgo intermedio
Mortalidad
CONFIRM
![Page 33: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/33.jpg)
15,207sujetos
Sospecha enfermedad coronaria
2.3±1.2 años
Riesgo intermedio
Mortalidad
CONFIRM
5,380 pacientes con enfermedad LIGERA en TC
Shaw et al. J Am Coll Cardiol 2012; 60:2103-14
![Page 34: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/34.jpg)
15,207sujetos
Sospecha enfermedad coronaria
2.3±1.2 años
Riesgo intermedio
Mortalidad
CONFIRM
2.799 pacientes con enfermedad obstructiva en TC
Shaw et al. J Am Coll Cardiol 2012; 60:2103-14
![Page 35: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/35.jpg)
Montalescot et al Eur H Journal 2013; 34:2949-3003
![Page 36: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/36.jpg)
Montalescot et al Eur H Journal 2013; 34:2949-3003
![Page 37: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/37.jpg)
Montalescot et al Eur H Journal 2013; 34:2949-3003
![Page 38: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/38.jpg)
Cho et al. J Am Coll Cardiol
2012; 60:2205-15.
Comparación capacidad pronóstica TC y ergometría
2.977 pacientes
• Retrospectivo• TC y ergo en menos de 90 días
Seguidos 3.3 años
97 eventos (3.3%)muerte/IAM/angina/revasc
12% ergos positivas
14% con lesiones
obstructivas
![Page 39: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/39.jpg)
Cho et al. J Am Coll Cardiol
2012; 60:2205-15.
Pacientes sin lesiones o con lesiones ligeras (obstrucción <40%)
Comparación capacidad pronóstica TC y ergometría
2.977 pacientes
• Retrospectivo• TC y ergo en menos de 90 días
Seguidos 3.3 años
97 eventos (3.3%)muerte/IAM/angina/revasc
![Page 40: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/40.jpg)
Cho et al. J Am Coll Cardiol
2012; 60:2205-15.
Pacientes con lesiones moderadas (40-70%)
Pacientes con lesiones severas (obstrucción>70%)
![Page 41: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/41.jpg)
Maksymilian et al. Am J Cardiol 2012; 109:1722-1728
Utilidad del TC para predecir el éxito de la revascularización quirúrgica en pacientes con oclusión completa de la DA
30 pacientes
• Oclusión DA • No candidato a cirugía por mal vaso en la angiografía
Diámetro > 1.5 mm
Sens 83% Espec 100%
Disminución de la angina
Mejor función ventricular
![Page 42: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/42.jpg)
Aldrovandi et al. Circulation 2012; 126:3000-3007
¿Son normales las arterias de los IAM con coronarias normales?
50 pacientes
• Coronarias sin lesiones • IAM confirmado RMN
101 placas - 42 pacientes
![Page 43: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/43.jpg)
![Page 44: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/44.jpg)
• Sospecha enfermedad coronaria• 71% varones
1.059 pacientes consecutivos Morfología de la placa
Baja densidad
Aparición de
SCAMotoyama et al. J Am Coll Cardiol 2009;49-57
Monitorización 27±10 meses
Estudio prospectivoRemodelado positivo
<30 HU >10%
![Page 45: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/45.jpg)
Motoyama et al. J Am Coll Cardiol 2009;49-57
22% a 2 años
2 criterios de riesgo
3.7% a 2 años
1 criterio de riesgo
0.5% a 2 años
0 criterios de riesgo
0.0% a 2 años
SIN lesiones
![Page 46: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/46.jpg)
895 sujetos
Sospecha enfermedad coronaria
> 1 año
Aparición SCA
Otsuka et al. J Am Coll Cardiol Img
2013; 6:448-57.
Signo del servilletero
![Page 47: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/47.jpg)
Otsuka et al. J Am Coll Cardiol Img
2013; 6:448-57.
Signo del servilletero
Baja atenuación
Remodelado positivo
![Page 48: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/48.jpg)
![Page 49: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/49.jpg)
Utilidad del gradiente de atenuación de contraste vs FFR invasivo
Wong et al. J Am Coll Cardiol2013;61:1271-9
Sens 77%, Spec 74%
TAG320 mayor que -15 UH/10 mm
Incrementa el rendimiento del TC
![Page 50: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/50.jpg)
DeFACTOMin et al. JAMA 2012;308:1237–1245
Multicéntrico
252 pacientes
Sospecha enf coronaria
![Page 51: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/51.jpg)
DeFACTOMin et al. JAMA 2012;308:1237–1245
Multicéntrico
252 pacientes
Sospecha enf coronaria
Mejora el rendimiento de la angio con TC
No invasivo
Resultado menos brillante de lo esperado
Sin poner medicación
Sin modificar protocolos
![Page 52: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/52.jpg)
DISCOVER-FLOWYoon et al. J Am Coll Cardiol Img 2012;5:1088-96
![Page 53: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/53.jpg)
Brian et al. J Am Coll Cardiol Img 2012;5:109-11
Anatomía y función con TC frente a reserva de flujo
![Page 54: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/54.jpg)
Bettenncourt et al. J Am Coll Cardiol 2013;61:1099–107
101 pacientes
TC, RMN, FFR
Isquemia con CT
Comparación isquemia TC y RMN frente angio con reserva flujo
TC Sens 89%, Spec 83%, VPP 80%, VPN 90% RMN Sens 89%, Spec 88%, VPP 85%, VPN 91%
![Page 55: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/55.jpg)
![Page 56: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/56.jpg)
Aplicación en clínica de la reconstruccion iterativa
Eisentopf et al. J Am Coll Cardiol Img2013;6:458-65
50 pacientes
2 x 128
Iterativo
87 stents
Síntomas
Sens 100%, Espec 74%VPP 85%VPN 100%
0.3 mSv
![Page 57: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/57.jpg)
Romero et al. Circ Cardiovasc Img
2013; 6:185-94
Metananalisis
19 estudios
2.955 pacientes
TC vs ETE
Sens 96% Espec 92%VPP 41% VPN 99%
Sens 100% Espec 99%VPP 92% VPN 100%
TC es una opción más que aceptable para descartar trombos en la orejuela
![Page 58: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/58.jpg)
Di Biase et al. J Am Coll Cardiol
2012; 60:531-8
932 pacientes
Estudio multicéntricoFA refractaria tto medico
TC o RMN para ver la orejuela
cactus
ala de pollo
manga viento
coliflor
Retrospectivo
Incidencia ACV previo
![Page 59: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/59.jpg)
Di Biase et al. J Am Coll Cardiol
2012; 60:531-8
![Page 60: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/60.jpg)
Di Biase et al. J Am Coll Cardiol
2012; 60:531-8
932 pacientes
Estudio multicéntricoFA refractaria tto medico
TC o RMN para ver la orejuela
![Page 61: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/61.jpg)
![Page 62: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/62.jpg)
Kasel et al. J Am Coll Cardiol Img 2013; 6:249 – 62
![Page 63: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/63.jpg)
Mahrabadi et al. J Am Coll Cardiol 2013; 61:1338-95
![Page 64: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/64.jpg)
Mahrabadi et al. J Am Coll Cardiol 2013; 61:1338-95
Comparativo
35p posición escopia por método convencional
Sistema automático para predecir el mejor ángulo para colocar la escopia en TAVI
36p posición escopia guiada por TC
![Page 65: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/65.jpg)
Ecocardiografía
Medicina nuclear
Cardio TC
Cardio RMN
![Page 66: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/66.jpg)
Moral et al. Rev Esp Cardiol 2012; 65:1010-17
![Page 67: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/67.jpg)
Monmeneu et al. Rev Esp Cardiol 2012; 65: 634-41
![Page 68: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/68.jpg)
Monmeneu et al. Rev Esp Cardiol 2012; 65: 634-41
16%
82%
![Page 69: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/69.jpg)
Monmeneu et al. Rev Esp Cardiol 2012; 65: 634-41
![Page 70: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/70.jpg)
Eitel et al. J Am Coll Cardiol 2013; 66: 613-22
![Page 71: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/71.jpg)
Merlos et al. Rev Esp Cardiol 2013; 66:613-22
![Page 72: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/72.jpg)
Schwitter et al. Eur Heart J 2013; 34:775-81
Comparación RMN de estres frente SPECT en detección de isquemia
![Page 73: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/73.jpg)
Jaarsma et al. J Am Coll Cardiol 2012; 59:1719-28
![Page 74: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/74.jpg)
Manka et al. Eur Heart Journal 2012; 33, 2016-24
![Page 75: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/75.jpg)
Leyva et al. J Am Coll Cardiol 2012; 60:1659-67
![Page 76: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/76.jpg)
Gulati et al. JAMA 2013 309 (9): 896-908
![Page 77: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/77.jpg)
Gulati et al. JAMA 2013 309 (9): 896-908
![Page 78: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/78.jpg)
T1 mapping
![Page 79: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/79.jpg)
![Page 80: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/80.jpg)
1. El ecocardiograma sigue siendo la técnica de referencia• Nuevos datos en eco de estrés• ¿El fin de la asincronía en ecocardiografía?• El famoso debate de la estenosis aórtica
2. El PET-TC es un avance espectacular para la evaluación de los casos difíciles de endocarditis
3. El Cardio TC está en plena fase de expansión • Formalmente incluido en las guías de práctica clínica• Desarrollo incesante de nuevas técnicas
4. La Cardio RMN se consolida como referencia en la evaluación del daño miocárdico • Tras el IAM• En todo tipo de miocardiopatías
![Page 81: News2013 sec](https://reader034.vdocument.in/reader034/viewer/2022051521/5a6577e77f8b9a06748b4a1f/html5/thumbnails/81.jpg)